Suggested Citation: "3 Opportunities for Real-World Data." National Academies of Sciences, Engineering, and Medicine. 2017. Real-World Evidence Generation and Evaluation of Therapeutics: Proceedings ...
AI’s progress has hit a critical constraint: access to real-world data. While public datasets and web scraping powered AI’s early breakthroughs, today’s models demand proprietary data from hospitals, ...
Why is tokenization important for the future of medicine development? A tremendous amount of data is collected throughout a clinical trial, but prior to tokenization, the life science industry did not ...
On December 15, 2025, the US Food and Drug Administration (FDA) issued a press release announcing that FDA eliminated a major barrier to the use of real-world evidence (RWE) in medical device ...
Real-World Data (RWD) has become one of the most widely discussed topics across the global medtech sector. But what is driving this increased attention? In reality, collecting data from clinicians and ...
Early-Stage Breast Cancer in Women Younger Than 50 Years: Comparing American Joint Committee on Cancer Anatomic and Prognostic Stages With Partitioning Around Medoids Clusters in SEER Data Large ...
The traditional process for evaluating new therapeutics may not generate the evidence that patients, clinicians, and payers need to make real-world decisions. The volume and complexity of information ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results